Caroline Litchfield has sold MRK and made no open-market buys since Nov 2021

Caroline A. Litchfield is Executive Vice President and Chief Financial Officer (EVP & CFO) of Merck & Co., Inc. (MRK), a position she has held since April 1, 2021, succeeding Robert M. Davis who advanced to CEO.( Prior to this, she served as Merck's Treasurer (2019–2021) and Senior Vice President of Finance for Global Human Health (2014–2018), overseeing financial operations in approximately 100 markets; she joined the company in 1990 in its U.K. business and advanced through various country, regional, and global finance roles.(

Litchfield, aged 56 as of recent records, has been instrumental in key strategic initiatives, including the integration of the $41.1 billion Merck-Schering-Plough merger in 2009 and leading the $11.5 billion acquisition of Acceleron Pharma in 2021.( Her responsibilities as CFO encompass finance, investor relations, procurement, facilities, treasury, tax, and business development, contributing to Merck's portfolio transformation and diversification efforts.( In 2024, she joined the board of directors at Verizon Communications (VZ) as an independent director.(

Written by Perplexity from public sources.